Revolutionizing cartilage recovery: Hy2Care’s CartRevive hydrogel implant enables optimal repair of cartilage defects and prevents patients from developing osteoarthritis. After sports mishaps, slips, or falls, our patented hydrogel offers a scaffold of joint-matching composition, guiding natural cell growth and enabling the body to heal itself. EU clinical trial fully enrolled, intermediate results strongly exceeding the standard of care, gearing towards the CE mark in 2026. FDA Breakthrough Device Designation ánd IDE approval; US trial to start in 2026. Dive into the future of joint repair with us!